APIE Therapeutics

APIE Therapeutics is a pioneer in developing therapeutic drug combinations for the treatment of chronic and debilitating diseases associated with vascular endothelial organ damage. APIE Therapeutics develops and commercializes new Apelin receptor-biased agonist drug therapies, activating the Apelinergic system and focusing on promising therapeutic targets within the Apelinergic system.